- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Canopy Growth confirmed an investment in a new cannabis brand called Houseplant created by Canadian actor Seth Rogen.
Canopy Growth (NYSE:CGC,TSX:WEED) has secured another celebrity business relationship thanks to its investment in a cannabis brand by actor Seth Rogen.
The brand, Houseplant, was founded by Rogen in collaboration with his creative partner, Evan Goldberg.
In a Wednesday (March 27) announcement, Canopy said it will aid Houseplant with “production and distribution capabilities.” According to the licensed producer (LP), the products from this brand are set to hit the Canadian market “over the coming months.”
The LP revealed that the partnership between the two groups was created after just under two years of working closely.
“Canopy Growth has worked closely with Houseplant for almost two years, and the entire Canopy Growth team is deeply impressed by [Houseplant’s] understanding of the cannabis consumer, attention to detail and hands-on approach to this new partnership,” the firm indicated to shareholders.
The Houseplant brand plans to offer strains of dried flower cannabis, softgel capsules and pre-rolled joints in the Canadian cannabis market.
The Canadian Press reported that Canopy gained a 25-percent stake in the Rogen company. However, details of the transaction were not disclosed.
“We could not be more passionate about this company, and we are dedicated to doing everything the right way,” Rogen told the Canadian Press. “It is extremely important to us to treat cannabis with the reverence it deserves.”
Shares of Canopy Growth were down 3.8 percent on the TSX to C$57.46 as of 1:08 p.m. EST on Wednesday. On the NYSE, the stock dipped 4.36 percent to US$42.75 as of 1:22 p.m. EST Wednesday.
Don’t forget to follow us @INN_Cannabis for real-time news updates!
Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.